Medical Management Rises to the Challenge of Academic Research—The Case of Gene Therapy

Weingart SN . Deciding to buy expensive technology—the case of biliary lithotripsy. Int J Technol Assess Health Care 1995;11:301–15.

Hudak RP , Brooke PP , Finstuen K , Riley P. Health care administration in the year 2000: practitioner's view of future issues and job requirements. Hospital and Health Services Administration 1993;38:184–95.

Porter ME . Competitive strategy: techniques for analyzing industries and competitors. New York: Free Press, 1980.

Yaad. A technological and marketing survey of gene therapy in Israel. Tel-Aviv: Commissioned by the Office of the Chief Scientist of the Ministry of Industry and Trade; 1996.

Hadassah Medical Organization. The Annual Report of the HMO. Jerusalem, (Israel): Hadassah Medical Organization, 1994.

Frost , Sullivan , eds. World gene therapies markets. California: A Market Intelligence Company, 1994.

Evers P. Gene therapy—present status and future prospects. Financial Times Management report. London: Financial Times Pharmaceuticals and Health Publishing, Pearson Professional Ltd., 1995.

Davidson S. Hidden biotechnology worth over $7.5 billion a year. Nature Biotechnology 1996;14:564.

Penchas S , Roll M. Organ transplantation: evolving a national transplantation policy and methodology in Israel. Transplant Proc 1996;28:2345–8.

Beckham ID . Crafting the new physician executive. Physician Executive 1995; 21:3–5.

Berns DS , Silbermann M. Overview of research in the medical sciences in Israel: institutions, investigators, and funding. Isr J Med Sci 1994;30:801–5.

Ministry of Science. Science in Israel: a practical guide 1996–97, Official publication Ministry of Science, 1997.